|
May 10
|
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
|
|
May 10
|
These Stocks Are Moving the Most Today
|
|
May 10
|
Stock markets, China tariffs, Novavax and Sanofi: 3 Things
|
|
May 10
|
US STOCKS-Futures rise ahead of data, speeches from Fed officials
|
|
May 10
|
Maze lands new partner for Pompe drug, after Sanofi pact came apart
|
|
May 10
|
Trending tickers: TSMC, Novavax, Anglo American and IAG
|
|
May 10
|
Q1 2024 Royalty Pharma PLC Earnings Call
|
|
May 9
|
Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash
|
|
May 9
|
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
|
|
May 8
|
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
|
|
May 8
|
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
|
|
May 8
|
Sanofi SA's Dividend Analysis
|
|
May 6
|
Update: Market Chatter: Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off
|
|
May 6
|
BofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi Spinoff
|
|
May 3
|
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Q1 2024 Kymera Therapeutics Inc Earnings Call
|
|
May 2
|
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
|
|
May 2
|
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
|
|
May 2
|
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
|
|
Apr 30
|
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
|